GTC Bio Cell & Gene Therapy Summit was held on September 11-12, 2017 in Boston, MA. This meeting brought together academia and industry to showcase several new technologies emerging in the field of cell and gene therapy.

Nick DeLong, Assocaite at Locust Walk co-authored with Anmol Grover, a consultant from Halloran Consulting Group on the following research: “Comprehensive Analysis of Drug Development and Transactional Deal Landscape for Neurodegenerative Disorders”. Anmol Grover presented the research during the conference on September 11. Nick leveraged Locust Walk’s deal experience to provide commentary and analysis on recent trends in deal making in the neurodegenerative disease space. Poster and data presented was very well received.

To view the research, please click here.